Breadcrumb Home Resources and Information Physicians and Scientists Resource Hub Discontinuation of Tyrosine Kinase Inhibitors In Pediatric Chronic Myeloid Leukemia Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia Pediatric Blood & Cancer , Apr 2022 Shima H et al. Pediatr Blood Cancer, April 2022 Link to full abstract Share Tweet Share Share